🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT05072626
Recruiting Observational

High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia

NCT05072626 · tracked via the Priya Life Science China tracker
Sponsor
Children's Hospital of Fudan University
Phase
Observational
Started
2021-10-11
Last updated
2026-04-03

Condition(s) studied

Biliary AtresiaInfantNutrition SupportMedium-chain Triglyceride

Study summary

This study is a prospective, single center and observational open clinical study.

Eligibility

Sex
ALL
Min age
Max age
3 Months
Healthy volunteers
No
Inclusion Criteria: The Kasai procedure for infants with biliary atresia under the age of 3 months. Exclusion Criteria: * Complicated with cirrhosis, hepatitis, or other hepatic disorders; * Complicated with other systemic serious diseases (such as congenital multiple malformations, chromosome abnormalities)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Children's Hospital of Fudan University Shanghai Shanghai Municipality Recruiting

More Children's Hospital of Fudan University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05072626 on ClinicalTrials.gov ↗ ← All trials in China